Image Source: AsiaOne
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-upNew Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology WorkstationGlobeNewswireMarch 31, 2023SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® Select Kit product line, releasing two novel kits to enable DNA amplification and scale-up.
Source: AsiaOne